NCT04997902 2025-12-23Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Kura Oncology, Inc.Phase 1/2 Completed45 enrolled
NCT07258979 2025-12-02A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.MediLink Therapeutics (Suzhou) Co., Ltd.Phase 1/2 Recruiting202 enrolled
NCT06016920 2024-12-17Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell CarcinomaNykode Therapeutics ASAPhase 1/2 Recruiting51 enrolled
NCT05357898 2024-02-23Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsSQZ BiotechnologiesPhase 1/2 Terminated20 enrolled
NCT04464967 2021-05-12Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersNKGen Biotech, Inc.Phase 1/2 Withdrawn